Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Tuberculosis, Emergency Medicine


Basics


Description


  • Tuberculosis (TB) is an infectious disease with protean manifestations, causing significant global morbidity and mortality.

Mechanism
  • Infectious droplet nuclei are inhaled through the respiratory tract.
  • Bacteria are dispersed through coughing, sneezing, speaking, singing.
  • Primary TB/latent TB infection (LTBI):
    • Initial infection occurs when organisms enter the alveoli, become engulfed by macrophages, and spread via regional lymph nodes to the bloodstream.
    • Patients are usually asymptomatic.
    • May be progressive/fatal in immunocompromised hosts.
    • Positive reaction to purified protein derivative (PPD) indicates past exposure or infection.
    • Negative PPD does not rule out active TB.
    • May progress to active TB (5 " “10%).
  • Reactivation TB:
    • LTBI becomes active TB.
    • Systemic (15%) and pulmonary (85%) symptoms.
  • TB affects about one-third of the worlds population (90 million new cases in the past decade worldwide, with about 30 million deaths).
  • Centers for Disease Control and Prevention (CDC) statistics from 2011 show TB in US at an all-time low.
  • TB rates in US have continued to decline since 1993.
  • Increase in US foreign-born cases
  • Still an estimated 10 " “15 million people are infected in US alone.

Etiology


  • Infection with Mycobacterium tuberculosis, a slow-growing, aerobic, acid-fast bacillus resulting in disease.
  • Humans are the only known reservoir.
  • Recent TB epidemics:
    • HIV-infected patients
    • Multidrug-resistant TB (MDR-TB)
    • Extensively drug-resistant TB (XDR-TB):
      • High mortality, few effective drugs

Diagnosis


Signs and Symptoms


  • Depending upon site of infection; all human tissues have potential for infection.
  • Pulmonary TB:
    • Cough
    • Fever, night sweats
    • Malaise, weight loss
    • Hemoptysis
    • Pleuritic chest pain
    • Shortness of breath
  • Extrapulmonary TB:
    • CNS infections:
      • Meningismus
      • Cranial nerve defects, diplopia
      • Headache, fever, malaise
      • Confusion
      • Acute ischemic stroke
    • Pericarditis:
      • Pleuritic chest pain increased with recumbency
    • Renal infection:
      • Fever
      • Flank pain
    • Spinal TB (Potts disease):
      • Back pain/stiffness, point tenderness
      • Fever
      • Decreased range of motion
    • Cervical lymphadenitis (scrofula):
      • Unilateral, painless
      • May form draining sinus tracts
    • Miliary TB:
      • Multiorgan system involvement
      • Diffuse adenopathy
      • Hepatomegaly
      • Splenomegaly
      • Weight loss, fever

History
Predisposing factors and conditions for TB: ‚  
  • HIV infection and other immunocompromised states (organ transplant, renal failure, diabetes)
  • Drug and alcohol abuse
  • Poverty, homelessness (living in shelters)
  • Institutionalization (nursing homes, prisons)
  • Immigration from an endemic area
  • Positive PPD test/previous infection

Physical Exam
  • Fever
  • Tachycardia
  • Hypoxia
  • Cachexia
  • Abnormal breath sounds
  • Cervical lymphadenopathy

Essential Workup


  • Diagnosis difficult due to the variety of clinical presentations.
  • Chest radiography:
    • Most valuable test for active pulmonary TB
  • Skin testing: PPD

Diagnosis Tests & Interpretation


Lab
  • CBC
  • Electrolytes, BUN, creatinine, glucose, LFTs
  • Hyponatremia (due to syndrome of inappropriate antidiuretic hormone)
  • ABGs for oxygenation/ventilation assessment
  • Sputum staining for acid-fast bacilli (Ziehl " “Neelsen stain):
    • Provides a quick presumptive diagnosis
  • Sputum, CSF, blood, urine, or peritoneal fluid culture:
    • Gold standard for diagnosis of TB
    • Average time for positive culture is 3 " “6 wk.
    • DNA polymerase chain reaction (PCR) testing more rapid
  • Lumbar puncture with CSF analysis:
    • For suspected TB meningitis
    • Elevated WBCs with lymphocyte predominance
    • Elevated protein
    • Low to normal glucose

Imaging
  • Chest radiograph:
    • May be normal
    • In primary disease, parenchymal infiltrates with unilateral hilar adenopathy are the classic findings.
    • Reactivation TB typically appears as cavitary lesions with or without calcification, usually in upper lung segments.
    • Miliary TB shows bilateral disseminated 2-mm nodules throughout lungs.
    • Chest radiograph may be nondefinitive in AIDS/immunocompromised patients.
    • Unilateral pleural effusion in both primary and reactivation TB
    • Tracheal deviation with scarring or atelectasis
    • Ghon focus " ”calcified scar/healed primary focus of infection
    • Ghon complex " ”primary infiltrate with associated unilateral hilar adenopathy
  • Spine radiographs for Potts disease:
    • May be normal
    • Anterior wedging of 2 involved vertebral bodies and destruction of disk
  • CT chest:
    • Better defines extent of disease

Diagnostic Procedures/Surgery
Skin testing: ‚  
  • Inject 0.1 mL of PPD intradermally in the forearm.
  • Positive test indicates prior or current infection with M. tuberculosis.
  • Test results are read between 48 and 72 hr after administration.
  • Interpretation of positive: >5-mm induration:
    • Close contacts with TB patients
    • Positive chest radiographs for TB
    • HIV-positive
    • Organ transplant or other immunosuppression
  • >10-mm induration:
    • IV drug users
    • Immigrants from high-prevalence countries (within 5 yr)
    • Underlying disease (diabetes, renal failure, malignancies)
    • Healthcare workers
    • Prison inmates
    • Institutionalized (nursing home, homeless shelters)
  • >15-mm induration:
    • Low-risk individuals

Differential Diagnosis


  • Bacterial pneumonia
  • Bronchiectasis
  • Coccidiomycosis
  • Histoplasmosis
  • Lung abscess
  • Lung carcinoma
  • Lymphoma
  • Pneumocystis carinii pneumonia
  • Pulmonary embolism
  • Sarcoidosis

Treatment


Pre-Hospital


  • Place patient in respiratory isolation (negative flow).
  • Place a mask on the patient to prevent respiratory spread of the disease.
  • Initiate treatment with an IV, oxygen, and pulse oximetry.
  • Endotracheal intubation may be required in patients with severe hemoptysis or respiratory compromise.
  • Providers should wear submicron particulate filter masks (N-95 designation).
  • Inform close contacts.

Initial Stabilization/Therapy


  • ABCs:
    • Control airway as needed.
    • Administer oxygen as needed.
    • Place on patient cardiac monitor and pulse oximetry.
    • Establish IV access with 0.9% normal saline
  • Isolate patients in negative pressure rooms with at least 6 air exchanges per hour.
  • Protection for healthcare workers (N-95 masks)

Ed Treatment/Procedures


  • Isolation and strict respiratory precautions
  • Treatment is augmented due to increasing multidrug resistance.
  • Any regimen must contain at least 2 drugs to which the TB bacillus is susceptible.
  • CDC currently recommends initial therapy that includes 4 1st-line drugs.
  • LTBI with normal chest x-ray given isoniazid (INH) for 9 mo or weekly combination of INH and rifapentine (RPT) for 12 wk.
  • Consult infectious disease specialists when treating HIV patients on antiretroviral therapies.
  • Add dexamethasone for TB meningitis.
  • Surgical drainage for TB empyema may be necessary; consult thoracic surgeon.
  • Directly observed therapy (DOT) may be necessary to ensure compliance in certain populations.
  • Intermittent (biweekly) regimen may demonstrate higher patient compliance.

Medication


First Line
  • INH: 5 mg/kg, max. 300 mg (peds: 10 " “15 mg/kg, max. 300 mg) PO/IM per day:
    • Refractory seizures in overdose, treat with pyridoxine 5 g IV over 5 min or PO
    • Caution with alcohol coingestion, hepatitis
  • Rifampin (RIF): 10 mg/kg, max. 600 mg (peds: 10 " “20 mg/kg, max. 600 mg) PO/IV per day
  • Pyrazinamide (PZA): 20 " “25 mg/kg/d max. 2 g (peds: 15 " “30 mg/kg/d) or:
    • <55 kg: 1 g PO per day
    • 56 " “75 kg: 1.5 g PO per day
    • >75 kg: 2 g PO per day
    • Not recommended in pregnancy
  • Ethambutol (ETB): 15 " “20 mg/kg, max. 1,600 mg (peds: 15 " “30 mg/kg, max. 1 g) PO per day or up to TID
    • Not recommended <13 yr old, requires visual testing
  • RPT: 10 mg/kg, max. 900 mg (peds: Not recommended <12 yr old) PO once per week or 300 mg PO weekly for 10 " “14 kg, 450 mg PO weekly for 14.1 " “25 kg, 600 mg PO weekly for 25.1 " “32 kg, 750 mg PO weekly for 32.1 " “49.9 kg, 900 mg PO weekly for >50 kg
  • Rifabutin: 5 mg/kg, max. 300 mg (peds: Unknown) PO per day

Second Line
(Less Effective, More Toxic)
  • Streptomycin: 15 mg/kg/d, max. 1 g (peds: 20 " “40 mg/kg/d) IM/IV per day:
    • Teratogenic: Contraindicated in pregnancy
  • Ethionamide: 0.5 " “1 g (peds: 10 " “20 mg/kg/d) PO div. QID
  • Levaquin: 750 mg (peds: Contraindicated) PO/IV per day

Follow-Up


Disposition


Admission Criteria
  • Respiratory compromise
  • Suspicion of diagnosis
  • Inability to comply with outpatient therapy
  • Unavailable outpatient resources (no PCP)
  • Involuntary admission for noncompliant outpatients occurs:
    • Be aware of respective state laws concerning involuntary admission (consult infectious disease specialist).

Discharge Criteria
  • Without respiratory compromise
  • Home isolation procedure compliance
  • Ability and willingness to comply with long-term therapy
  • Appropriate outpatient follow-up and treatment available
  • Notification of the public health authorities is mandatory.

Issues for Referral
Referral to Department of Public Health for DOT ‚  

Follow-Up Recommendations


  • Sputum analysis periodically to document clearance
  • Medication toxicity monitoring:
    • INH, RIF, PZA: Monitor liver function tests for hepatitis
    • PZA: Check uric acid levels
    • ETB: Eye testing for color blindness

Pearls and Pitfalls


  • Early isolation and respiratory precautions
  • Careful history to establish risk factors
  • The chest x-ray and PPD are great diagnostic aids.
  • Initial 4-drug regimen for active disease
  • Nonadherent, active TB patients are considered a public health hazard:
    • Specific state laws are applicable in numerous areas.

Additional Reading


  • American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep.  2003;52(RR-11):1 " “77.
  • American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling tuberculosis in the United States. Am J Respir Crit Care Med.  2005;172:1169 " “1227.
  • Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR.  2011;60(RR-48):1650 " “1653.
  • Moran ‚  GJ, Talan ‚  DA.Tuberculosis. In: Wolfson ‚  AB, ed. Harwood-Nuss ' Clinical Practice ofEmergency Medicine. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins: 2010:912 " “917.
  • Taylor ‚  Z, Nolan ‚  CM, Blumberg ‚  HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep.  2005;54(RR-12):1 " “81. http://www.cdc.gov/tb/publications/factsheets/statistics/TBTrends.html. Accessed on February 28, 2013.

See Also (Topic, Algorithm, Electronic Media Element)


  • Pneumonia, Adult
  • Bronchiectasis
  • Coccidiomycosis
  • Histoplasmosis
  • Lymphoma
  • Pneumocystis carinii Pneumonia
  • Pulmonary Embolism
  • Sarcoidosis

Codes


ICD9


  • 010.90 Primary tuberculous infection, unspecified, unspecified
  • 011.90 Unspecified pulmonary tuberculosis, unspecified
  • 795.51 Nonspecific reaction to tuberculin skin test without active tuberculosis
  • 018.90 Miliary tuberculosis, unspecified, unspecified
  • 013.20 Tuberculoma of brain, unspecified
  • 017.90 Tuberculosis of other specified organs, unspecified

ICD10


  • A15.7 Primary respiratory tuberculosis
  • A15.9 Respiratory tuberculosis unspecified
  • R76.11 Nonspecific reaction to skin test w/o active tuberculosis
  • A19.9 Miliary tuberculosis, unspecified
  • A17.81 Tuberculoma of brain and spinal cord
  • A18.84 Tuberculosis of heart
  • A18.89 Tuberculosis of other sites

SNOMED


  • 56717001 Tuberculosis (disorder)
  • 63309002 Primary tuberculosis (disorder)
  • 441846005 Nonspecific tuberculin test reaction (finding)
  • 47604008 Miliary tuberculosis (disorder)
  • 302131003 Tuberculosis of heart (disorder)
  • 31112008 Tuberculous meningoencephalitis (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer